Invesco Ltd. - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$2,351,344
+457.6%
179,355
+988.1%
0.00%
Q2 2023$421,661
+21.7%
16,484
+19.8%
0.00%
Q1 2023$346,615
+21.6%
13,760
+11.0%
0.00%
Q4 2022$285,076
-6.5%
12,400
-10.1%
0.00%
Q3 2022$305,000
+77.3%
13,795
+14.6%
0.00%
Q2 2022$172,000
-21.8%
12,037
+3.1%
0.00%
Q1 2022$220,000
-1.3%
11,673
-2.7%
0.00%
Q4 2021$223,00012,0030.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,537,271$38,723,8564.26%
Millrace Asset Group, Inc. 72,595$1,8292.13%
Divisadero Street Capital Management, LP 175,000$4,408,2501.93%
Perceptive Advisors 2,442,250$61,520,2781.82%
SECTORAL ASSET MANAGEMENT INC 366,443$9,230,6991.77%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,234,8411.67%
EMERALD ADVISERS, LLC 1,363,453$34,345,3811.65%
FORMULA GROWTH LTD 124,900$3,146,2311.01%
Novo Holdings A/S 540,000$13,602,6000.90%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 755,379$19,027,9970.78%
View complete list of TREACE MED CONCEPTS INC shareholders